Agios to Webcast Conference Call of First Quarter 2020 Financial Results on April 30, 2020
April 16 2020 - 7:00AM
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field
of cellular metabolism to treat cancer and rare genetic diseases,
today announced that the company will host a conference call and
live webcast on Thursday, April 30, 2020 at 8:00 a.m. ET to report
its first quarter 2020 financial results and other business
highlights.
A live webcast can be accessed under "Events
& Presentations" in the Investors section of the company's
website at www.agios.com. The conference call can be accessed by
dialing 1-877-377-7098 (domestic) or 1-631-291-4547 (international)
and referring to conference ID 1151878. The webcast will be
archived and made available for replay on the company's website
beginning approximately two hours after the event.
About AgiosAgios is focused on
discovering and developing novel investigational medicines to treat
malignant hematology, solid tumors and rare genetic diseases
through scientific leadership in the field of cellular metabolism.
In addition to an active research and discovery pipeline across
these three therapeutic areas, Agios has two approved oncology
precision medicines and multiple first-in-class investigational
therapies in clinical and/or preclinical development. For more
information, please visit the company's website at
www.agios.com.
Contacts
Investors:Holly Manning,
617-844-6630Director, Investor RelationsHolly.Manning@agios.com
Media:Jessica Rennekamp,
857-209-3286Associate Director, Corporate
CommunicationsJessica.Rennekamp@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Sep 2023 to Sep 2024